US Weight‑Loss Drug Prices Fall as Competition Intensifies US weight‑loss drug prices are falling after 2021 FDA approvals; CDC estimates adult obesity at 41.9% (2017–2020) and Novo held ~70% market share by end‑2024 (company filings).

US Weight‑Loss Drug Prices Fall as Competition Intensifies: US weight‑loss drug prices are falling after 2021 FDA approvals; CDC estimates adult obesity at 41.9% (2017–2020) and Novo held ~70% market share by end‑2024… 👈 Read full analysis #WeightLoss #Obesity #Health #FDAApprovals #Pharmaceuticals

📚Meet MedChemExpress Series | #FDAApprovals 2025
The U.S. FDA has approved 40+ novel drugs as of December 2025, covering #oncology, #RareDiseases, #neuroscience, infectious diseases, ophthalmology, and cardiovascular & metabolic disorders.
Explore more: ow.ly/pOAW50XVgnX

2025 FDA approvals (as of Dec 1): 38 novel drugs • 28 small molecules (74%)
67% of those are chiral — highest % in FDA history (1951–2025)
After years of biologics rising, 2025 is the year of the comeback for single-enantiomer drugs.
#FDAApprovals #Chirality #DrugDiscovery

UK and US unite to fast-track medical innovation - PharmaTimes New MHRA–FDA collaboration aims to boost patient access and AI safety

#MHRAFDAcollaboration #patientaccess #AIsafety #MHRA #FDA #medicaltechnologies #Medtech #AI #AdvancedMedicalTechnologyAssociation #NationalAICommission #AIinhealthcare #marketaccess #innovativetechnologies #FDAapprovals #medicaldevices #TotalProductLifeCycleAdvisoryProgram
zurl.co/iEOJV

Dostarlimab (Jemperli) 2025 Updates: What Patients Need to Know? - OncoDaily Learn more about Dostarlimab (Jemerli), its uses, dosage, side effects, and what patients should expect during treatment.

Dostarlimab (Jemperli) 2025 Updates: What Patients Need to Know?

oncodaily.com/drugs/dostar...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Dostarlimab #Jemperli #EndometrialCancer #FDAapprovals #Immunotherapy

Rare Diseases Weekly News – July 10th 2025 🧬 This Week in Rare Diseases: Global Policy Shifts, FDA Approvals, New Gene Therapies, a $20M CRISPR Push and More […] The post Rare Diseases Weekly News – July 10th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Rare Diseases Weekly News – July 10th 2025 #News #clinicaltrials #crispr #FDAApprovals Comment below!

Rare Diseases Weekly News – July 10th 2025 🧬 This Week in Rare Diseases: Global Policy Shifts, FDA Approvals, New Gene Therapies, a $20M CRISPR Push and More […] The post Rare Diseases Weekly News – July 10th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Rare Diseases Weekly News – July 10th 2025 #News #clinicaltrials #crispr #FDAApprovals Comment below!

Rare Diseases Weekly News – July 10th 2025 🧬 This Week in Rare Diseases: Global Policy Shifts, FDA Approvals, New Gene Therapies, a $20M CRISPR Push and More […] The post Rare Diseases Weekly News – July 10th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Rare Diseases Weekly News – July 10th 2025 #News #clinicaltrials #crispr #FDAApprovals Comment below!

Vorasidenib (Voranigo): What patients need to know? - OncoDaily Learn about Vorasidenib (Voranigo), its uses in cancer, side effects, dosage, administration, and what should patients expect during treatment.

Vorasidenib (Voranigo): What patients need to know?

oncodaily.com/drugs/vorasi...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Vorasidenib #Voranigo #Astrocytoma #BrainTumors #Drugs #FDAapprovals #Oligodendroglioma

Vorasidenib (Voranigo): Uses in Cancer, Side Effects, Dosage, Expectations, and More - OncoDaily Learn about Vorasidenib (voranigo), its uses in cancer treatment, side effects, dosage, and expectations. It is used for IDH mutated brain tumors.

Vorasidenib (Voranigo): Uses in Cancer, Side Effects, Dosage, Expectations, and More

oncodaily.com/drugs/vorasi...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Vorasidenib #Voranigo #Astrocytoma #BrainTumor #Drugs #FDAapprovals #Glioma #Oligodendroglioma

🚨 FDA’s next wave of cancer decisions is coming fast.

From HER2+ to brain tumors, these approvals could reset standards in 2025.

Belzutifan, ONC201, TLX250-CDx, and more are on deck.

♻️ Repost 💡 Follow @sbokhiria.bsky.social

#FDAApprovals #Oncology #Biotech #CancerCare #KiriaResearch

Top 5 women's health headlines you missed in April 2025 Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.

April 2025 saw major updates in OB/GYN, from #FDAApprovals to key clinical trials. Explore the latest in maternal-fetal medicine, reproductive health, and more. #MaternalHealth

Read more: www.contemporaryobgyn.net/view/top-5-w...

Sulfur- and phosphorus-containing FDA approved drugs in the last five years (2020–2024): A journey among small molecules Sulfur and phosphorus are elements that can be found in various FDA-approved drugs, either as part of the active pharmaceutical ingredients (APIs) or as components of excipients (inactive ingredien...

🔬 New Publication Alert! 🧪

"Sulfur- and phosphorus-containing FDA approved drugs in the last five years (2020–2024): A journey among small molecules"

📄 Read the full article here: www.tandfonline.com/doi/full/10....

#MedicinalChemistry #DrugDiscovery #Sulfur #Phosphorus #Drugs #FDAApprovals

FDA Expands Diazepam Nasal Spray Indication to Treat Ages 2 to 5 The intranasal treatment, originally marketed in 2020, will now be available for patients with acute repetitive seizures as young as 2 years old.

#BREAKING: The FDA has approved an expanded indication for diazepam nasal spray (Valtoco; Neurelis), now allowing its use in children ages 2 to 5 for the treatment of seizure clusters, also known as acute repetitive #seizures. #FDAApprovals

Read more: www.neurologylive.com/view/fda-exp...

#FDAapprovals from last week ICYMI:

GSK’s Penmenvy Vaccine for Meningococcal Serogroups A, B, C, W, and Y for individuals aged 10-25:
www.contagionlive.com/view/fda-app...

Bavarian Nordic’s Chikungunya Vaccine for those aged 12 and older: www.contagionlive.com/view/fda-app...

#IDsky #MEDsky

Oncology leads the way! 🚀
🧬 In 2024, the FDA approved ✅50 new therapies, with 15 (30%) 🎯targeting cancer – including multiple first-in-class therapies and the 11th PD1/PDL1 inhibitor.
@oncoalert.bsky.social #Oncology #FDAApprovals #Innovation

nature.com/articles/d4157…